Full Agonist - Toxicology

Relevant Publications

Measuring Calcium-Sensing Receptor Agonist-Driven Insertional Signaling (ADIS) and Trafficking by TIRF Microscopy.

Issue Release: 2025

Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch.

Issue Release: 2024

Novel Isoforms of Adhesion G Protein-Coupled Receptor B1 (ADGRB1/BAI1) Generated from an Alternative Promoter in Intron 17.

Issue Release: 2024

Reconsidering the usefulness of long-term high-dose buprenorphine.

Issue Release: 2024

Revealing the graded activation mechanism of neurotensin receptor 1.

Issue Release: 2024

Effects of (poly)phenols on circadian clock gene-mediated metabolic homeostasis in cultured mammalian cells: a scoping review.

Issue Release: 2024

Safety profiles of offspring born from early-follicular long-acting GnRH agonist protocol and daily mid-luteal GnRH agonist protocol: a retrospective study.

Issue Release: 2024

Surgical removal of extended-release buprenorphine depot due to adverse reactions.

Issue Release: 2024

Buprenorphine Use for Analgesia in Palliative Care.

Issue Release: 2024

MASLD/MASH and type 2 diabetes: two sides of the same coin? From single PPAR to pan-PPAR agonists.

Issue Release: 2024

Synthetic Peptides Capable of Potent Multigroup Quorum Sensing Activation and Inhibition in Both Cultures and Biofilm Communities.

Issue Release: 2024

Rotating palliative care patients from full agonist opioids to low dose milligram buprenorphine.

Issue Release: 2024

Structural proteomics defines a sequential priming mechanism for the progesterone receptor.

Issue Release: 2024

Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways.

Issue Release: 2024

An individual-based dynamic model to assess interventions to mitigate opioid overdose risk.

Issue Release: 2024

In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays.

Issue Release: 2024

Dietary Protein Defends Lean Mass and Maintains the Metabolic Benefits of Glucagon Receptor Agonism in Mice.

Issue Release: 2024

TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models.

Issue Release: 2024

Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials.

Issue Release: 2024

The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression.

Issue Release: 2024

What is Occupational Health in the Context of Toxicology?

What are Firewalls in Toxicology?

Why is NF-ÎºB considered a double-edged sword in toxicology?

How are These Reactions Diagnosed?

What are the Challenges Associated with Recusal?

What Role Does Public Participation Play in EPA’s Work?

Why is Non-Invasive Testing Important?

How Do Optical Technologies Work in Toxicology?

How to Prevent Toxicity Related Illnesses?

How Does Radioactive Iodine Therapy Work?

Partnered Content Networks

Relevant Topics